AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33586578 — intervention group
Group type: EXPERIMENTAL
Intervention: Loud personal listening device (PLD) usage
Number of subjects: 4807
Study 33586578 — intervention group
Group type: EXPERIMENTAL
Intervention: High PLD usage (equivalent to or above 85 dBA, LEX 40)
Number of subjects: 4807
Study 33586578 — intervention group
Group type: EXPERIMENTAL
Intervention: Five years or more of loud PLD usage
Number of subjects: 4807
Study 33586578 — intervention group
Group type: EXPERIMENTAL
Intervention: Loud or high PLD usage
Number of subjects: 4807
Study 33225646 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery (ERAS) protocol
Number of subjects: 150
Study 33225646 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 150
Study 35584639 — intervention group
Group type: EXPERIMENTAL
Intervention: Inference-based cognitive-behavioral therapy (I-CBT)
Number of subjects: 111
Study 35584639 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 111
Study 35584639 — intervention group
Group type: COMPARATOR
Intervention: Appraisal-based cognitive behavioral therapy (A-CBT)
Number of subjects: 111
Study 33968872 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component training program (12 hours total duration)
Number of subjects: 25
Study 33968872 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component training program (minimum of 8 hours)
Number of subjects: 25
Study 33968872 — intervention group
Group type: COMPARATOR
Intervention: Baseline assessment
Number of subjects: 25
Study 35661128 — intervention group
Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 55
Study 32313142 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) plus docetaxel
Number of subjects: 790
Study 32313142 — intervention group
Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) alone
Number of subjects: 790
Study 35430239 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized 3D printed pillboxes
Number of subjects: 15
Study 35430239 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized off‐the‐shelf pillboxes
Number of subjects: 15
Study 34113093 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nemiralisib (1 mg)
Number of subjects: 126
Study 34113093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 32323191 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (twice-daily dosing)
Number of subjects: 0
Study 32323191 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (once-daily dosing)
Number of subjects: 0
Study 32323191 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (both dosing periods)
Number of subjects: 0
Study 32066302 — intervention group
Group type: EXPERIMENTAL
Intervention: Pine-tar bath oil
Number of subjects: 0
Study 32450914 — intervention group
Group type: EXPERIMENTAL
Intervention: Wolbachia-infected Aedes aegypti deployments
Number of subjects: 0
Study 32450914 — intervention group
Group type: COMPARATOR
Intervention: Untreated clusters
Number of subjects: 0
Study 35319737 — intervention group
Group type: EXPERIMENTAL
Intervention: Question prompt list brochure
Number of subjects: 446
Study 35319737 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 446
Study 35319737 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeon reluctance to operate
Number of subjects: 446
Study 35319737 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer conversations
Number of subjects: 446
Study 35590791 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol consumption (beer) with a mixed meal
Number of subjects: 12
Study 35590791 — intervention group
Group type: COMPARATOR
Intervention: Non-alcohol scenario
Number of subjects: 12
Study 33624071 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic training (AT)/resistance training (RT)/inspiratory muscle training (IMT) (ARIS)
Number of subjects: 88
Study 32376984 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT) - 40 minutes of cycling at 50-75% heart rate reserve, 2 times a week for 8 weeks
Number of subjects: 42
Study 32376984 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) - 6 resistance exercises, 4 × 12 repetitions at 60% maximum strength, 2 times a week for 8 weeks
Number of subjects: 42
Study 32376984 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Training (CT) - 2 × 12 repetitions of RT + 20 minutes of AT, 2 times a week for 8 weeks
Number of subjects: 42
Study 35265985 — intervention group
Group type: EXPERIMENTAL
Intervention: Contezolid 800 mg q12h
Number of subjects: 626
Study 35265985 — intervention group
Group type: COMPARATOR
Intervention: Linezolid 600 mg q12h
Number of subjects: 626
Study 35895867 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 2306
Study 34880300 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal Oxytocin (OT) 24 IU
Number of subjects: 40
Study 34880300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33152067 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief alcohol intervention (BAI) delivered by computer-generated individualized feedback letters at baseline, 3 and 6 months
Number of subjects: 1646
Study 33152067 — intervention group
Group type: COMPARATOR
Intervention: Assessment only (Control)
Number of subjects: 1646
Study 32171297 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole case format
Number of subjects: 142
Study 32171297 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial cue case format
Number of subjects: 142
Study 32171297 — intervention group
Group type: COMPARATOR
Intervention: Whole case and serial cue formats
Number of subjects: 142
Study 32171297 — intervention group
Group type: EXPERIMENTAL
Intervention: High prior knowledge students
Number of subjects: 142
Study 32171297 — intervention group
Group type: EXPERIMENTAL
Intervention: Low prior knowledge students
Number of subjects: 142
Study 35870491 — intervention group
Group type: COMPARATOR
Intervention: DMEK vs UT‐DSAEK
Number of subjects: 50
Study 33602441 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 14628
Study 33602441 — intervention group
Group type: COMPARATOR
Intervention: Dual-antiplatelet therapy (DAPT)
Number of subjects: 14628
Study 35092544 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga with active tDCS (2 mA; 20 min; anode-F3, cathode-F4)
Number of subjects: 22
Study 35092544 — intervention group
Group type: COMPARATOR
Intervention: Yoga with sham tDCS
Number of subjects: 22
Study 33600918 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashwagandha root extract (300 mg, twice daily for 8 weeks)
Number of subjects: 50
Study 33600918 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashwagandha root extract
Number of subjects: 50
Study 34789346 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with highest STPP inclusion level and lowest Ca:P
Number of subjects: 24
Study 34789346 — intervention group
Group type: EXPERIMENTAL
Intervention: All experimental diets
Number of subjects: 24
Study 34789346 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with intended total Ca:P of about 1.0, 1.5 or 2.0
Number of subjects: 24
Study 33801337 — intervention group
Group type: EXPERIMENTAL
Intervention: Co‐Cr ceramic prosthesis (conventional method)
Number of subjects: 95
Study 33801337 — intervention group
Group type: EXPERIMENTAL
Intervention: Co‐Cr ceramic prostheses (CAD/CAM technique)
Number of subjects: 95
Study 33801337 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia‐based prostheses (CAD/CAM technique)
Number of subjects: 95
Study 34176657 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomy-based retraining program (MusAARP)
Number of subjects: 4
Study 32125300 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual milled transdental implants made of zirconium dioxide; patients with apical periodontitis of incisors, canines or premolars.
Number of subjects: 96
Study 32125300 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual milled transdental implants made of zirconium dioxide; patients with similar diagnosis and concomitant periodontitis of moderate severity.
Number of subjects: 96
Study 32125300 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual milled transdental implants made of zirconium dioxide; patients with periapical destructive process of molars without periodontitis.
Number of subjects: 96
Study 32125300 — intervention group
Group type: COMPARATOR
Intervention: Resection of the root apex without implantation; control group.
Number of subjects: 96
Study 33608007 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted lung denervation (TLD) therapy
Number of subjects: 34
Study 36082054 — intervention group
Group type: EXPERIMENTAL
Intervention: 640-slice CT scan
Number of subjects: 120
Study 36082054 — intervention group
Group type: COMPARATOR
Intervention: Conventional CT scan
Number of subjects: 120
Study 35056313 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive assessment (MMSE/MoCA)
Number of subjects: 76
Study 35056313 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilometric platform measurements
Number of subjects: 76
Study 35056313 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 76
Study 35056313 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue syndrome assessment using the Fatigue Severity Scale (FSS)
Number of subjects: 76
Study 33298133 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to UMIMS educational tool
Number of subjects: 120
Study 33298133 — intervention group
Group type: COMPARATOR
Intervention: Access to control website
Number of subjects: 120
Study 35043428 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax plus hypomethylating agent (HMA)
Number of subjects: 771
Study 35043428 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax plus low-dose cytarabine (LDAC)
Number of subjects: 771
Study 35043428 — intervention group
Group type: COMPARATOR
Intervention: Venetoclax plus HMA
Number of subjects: 771
Study 35043428 — intervention group
Group type: COMPARATOR
Intervention: Venetoclax plus LDAC
Number of subjects: 771
Study 35043428 — intervention group
Group type: COMPARATOR
Intervention: Venetoclax
Number of subjects: 771
Study 35043428 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 771
Study 33682260 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical circulatory support (MCS) devices
Number of subjects: 0
Study 34514959 — intervention group
Group type: EXPERIMENTAL
Intervention: Illusion group (watched own finger joint movement video image and induced kinesthetic illusion)
Number of subjects: 30
Study 34514959 — intervention group
Group type: EXPERIMENTAL
Intervention: Illusion group
Number of subjects: 30
Study 34514959 — intervention group
Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 30
Study 34514959 — intervention group
Group type: COMPARATOR
Intervention: Motor execution group
Number of subjects: 30
Study 32247156 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐PRE‐DELIRIC score
Number of subjects: 1506
Study 32247156 — intervention group
Group type: EXPERIMENTAL
Intervention: PRE‐DELIRIC score
Number of subjects: 1506
Study 32247156 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐PRE‐DELIRIC and PRE‐DELIRIC scores
Number of subjects: 1506
Study 33743831 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral isotretinoin treatment
Number of subjects: 60
Study 33743831 — intervention group
Group type: COMPARATOR
Intervention: Control group (local treatment)
Number of subjects: 60
Study 32326621 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1200 IU) for 26 weeks
Number of subjects: 152
Study 32326621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 34814867 — intervention group
Group type: EXPERIMENTAL
Intervention: cinpanemab, a monoclonal antibody against alpha‐synuclein
Number of subjects: 482
Study 32054543 — intervention group
Group type: EXPERIMENTAL
Intervention: PS + FO (3.3 g/d PS and 450 mg EPA + 1500 mg DHA/d)
Number of subjects: 96
Study 32054543 — intervention group
Group type: EXPERIMENTAL
Intervention: PS (3.3 g/d)
Number of subjects: 96
Study 32054543 — intervention group
Group type: EXPERIMENTAL
Intervention: FO (450 mg EPA + 1500 mg DHA/d)
Number of subjects: 96
Study 32054543 — intervention group
Group type: COMPARATOR
Intervention: PO (placebo)
Number of subjects: 96
Study 33945036 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater occipital nerve block (GONB) with local anesthetic and triamcinolone
Number of subjects: 54
Study 33945036 — intervention group
Group type: COMPARATOR
Intervention: Detoxification without GONB (Control group)
Number of subjects: 54
Study 32504217 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-cleaning device
Number of subjects: 20
Study 32504217 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrushing
Number of subjects: 20
Study 32241780 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan + Statin
Number of subjects: 2815
Study 32241780 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Statin
Number of subjects: 2815
Study 35022546 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intervention group
Number of subjects: 2684
Study 35022546 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intervention + face-to-face counselling group
Number of subjects: 2684
Study 35022546 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2684
Study 35022546 — intervention group
Group type: EXPERIMENTAL
Intervention: No attempts to lose weight
Number of subjects: 2684
Study 35022546 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-2 attempts
Number of subjects: 2684
Study 35022546 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 or more attempts
Number of subjects: 2684
Study 32776347 — intervention group
Group type: EXPERIMENTAL
Intervention: Home parenteral nutrition (PN) or customized intravenous fluid (IVF) support for IBD patients
Number of subjects: 25
Study 32776347 — intervention group
Group type: COMPARATOR
Intervention: Control group of IBD patients
Number of subjects: 25
Study 34453208 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic MiniMed® Advanced Hybrid Closed-Loop (AHCL)
Number of subjects: 59
Study 34453208 — intervention group
Group type: COMPARATOR
Intervention: Sensor Augmented Pump therapy with Predictive Low Glucose Management (SAP + PLGM)
Number of subjects: 59
Study 32035738 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Conversation Skills (client‐centered communication approach)
Number of subjects: 70
Study 32035738 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Healthy Conversation Skills)
Number of subjects: 70
Study 32035738 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Conversation Skills
Number of subjects: 70
Study 35084022 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir plus Dexamethasone
Number of subjects: 151
Study 35084022 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone alone
Number of subjects: 151
Study 33992038 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental feeding tube device (SFTD)
Number of subjects: 46
Study 33992038 — intervention group
Group type: COMPARATOR
Intervention: Bottle method (control)
Number of subjects: 46
Study 35917660 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing pre-wounding
Number of subjects: 122
Study 35917660 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing
Number of subjects: 122
Study 35917660 — intervention group
Group type: COMPARATOR
Intervention: Healed wounds
Number of subjects: 122
Study 35917660 — intervention group
Group type: COMPARATOR
Intervention: Control writing
Number of subjects: 122
Study 34534770 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary self-monitoring via MyFitnessPal for one month
Number of subjects: 20
Study 35227242 — intervention group
Group type: EXPERIMENTAL
Intervention: Respite care (home-based services)
Number of subjects: 62
Study 35227242 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study 32197714 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-body medicine use among women with gynecological cancer
Number of subjects: 26742
Study 32197714 — intervention group
Group type: COMPARATOR
Intervention: Mind-body medicine use among women without gynecological cancer
Number of subjects: 26742
Study 34425226 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (200 mg testosterone enanthate per week in sesame oil)
Number of subjects: 50
Study 34425226 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sesame seed oil only)
Number of subjects: 50
Study 32073662 — intervention group
Group type: EXPERIMENTAL
Intervention: Favorable high-risk disease
Number of subjects: 3033
Study 35146830 — intervention group
Group type: EXPERIMENTAL
Intervention: iNPWT (PICO™, Smith&Nephew)
Number of subjects: 80
Study 35146830 — intervention group
Group type: COMPARATOR
Intervention: Standard dressing (Steri‐Strips™) with suction drain
Number of subjects: 80
Study 32490771 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular catheter + anesthetics (bupivacaine)
Number of subjects: 100
Study 32490771 — intervention group
Group type: COMPARATOR
Intervention: Intraarticular catheter + placebo (physiological serum)
Number of subjects: 100
Study 32490771 — intervention group
Group type: EXPERIMENTAL
Intervention: Subfascial catheter + anesthetics (bupivacaine)
Number of subjects: 100
Study 32490771 — intervention group
Group type: COMPARATOR
Intervention: Subfascial catheter + placebo (physiological serum)
Number of subjects: 100
Study 35405085 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus abiraterone (oral 1000 mg abiraterone once daily plus oral 5 mg prednisone twice daily)
Number of subjects: 1173
Study 35405085 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus abiraterone
Number of subjects: 1173
Study 35405085 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (androgen deprivation therapy alone or with intravenous docetaxel 75 mg/m2 once every 3 weeks)
Number of subjects: 1173
Study 33484566 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment strategies including training workshops for medical staff and telemedicine technology
Number of subjects: 0
Study 33484566 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 33249812 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health intervention (personalized guidance via WeChat Mini Program Rehabilitation Cloud Platform)
Number of subjects: 125
Study 33249812 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health intervention
Number of subjects: 125
Study 36493840 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive BP lowering strategy (Systolic BP target <120 mm Hg)
Number of subjects: 11255
Study 36493840 — intervention group
Group type: COMPARATOR
Intervention: Standard BP lowering strategy (Systolic BP target <140 mm Hg)
Number of subjects: 11255
Study 36493840 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive BP lowering strategy
Number of subjects: 11255
Study 36493840 — intervention group
Group type: COMPARATOR
Intervention: Standard BP lowering strategy
Number of subjects: 11255
Study 33154570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab plus FOLFIRI
Number of subjects: 593
Study 33154570 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab plus FOLFIRI
Number of subjects: 593
Study 32540720 — intervention group
Group type: EXPERIMENTAL
Intervention: Active anodal tDCS combined with robotic-assisted gait training (RAGT)
Number of subjects: 39
Study 32540720 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline high-beta EEG oscillations power
Number of subjects: 39
Study 32540720 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreases in relative high-beta power and increases in beta power during walking
Number of subjects: 39
Study 32540720 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS combined with robotic training
Number of subjects: 39
Study 33933596 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 29
Study 33933596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 33785481 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-dense temozolomide plus zotiraciclib
Number of subjects: 53
Study 33785481 — intervention group
Group type: COMPARATOR
Intervention: Metronomic temozolomide plus zotiraciclib
Number of subjects: 53
Study 33785481 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotiraciclib
Number of subjects: 53
Study 33979763 — intervention group
Group type: EXPERIMENTAL
Intervention: TNX-102 SL 5.6 mg
Number of subjects: 231
Study 33979763 — intervention group
Group type: COMPARATOR
Intervention: TNX-102 SL
Number of subjects: 231
Study 33979763 — intervention group
Group type: EXPERIMENTAL
Intervention: TNX-102 SL 2.8 mg
Number of subjects: 231
Study 33979763 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231
Study 32266856 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher depressive symptoms
Number of subjects: 455
Study 32266856 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-person depressive symptoms
Number of subjects: 455
Study 32266856 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of within-person perceived social support
Number of subjects: 455
Study 34687810 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush A (medium-hard, compact head)
Number of subjects: 80
Study 34687810 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush B (medium-hard, regular head)
Number of subjects: 80
Study 34687810 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush C (medium-hard, compact head)
Number of subjects: 80
Study 34687810 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush D (soft, compact head)
Number of subjects: 80
Study 34766453 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led counselling and education (two face-to-face sessions, two telephone sessions)
Number of subjects: 120
Study 34766453 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 120
Study 32447442 — intervention group
Group type: EXPERIMENTAL
Intervention: Early drainage by ureteral stenting (within 48 hours after admission)
Number of subjects: 238
Study 32447442 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 238
Study 32447442 — intervention group
Group type: EXPERIMENTAL
Intervention: Early drainage
Number of subjects: 238